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Definitions and abbreviations  
 
Competence: the ability of bacterial cells  to take up extracellular (‘naked’) DNA from their 
surroundings by making use of a dedicated membrane system. 
Conjugation: Transmission of foreign DNA via physical contact between donor and recipient 
bacterial cells. 
Conjugative plasmid: Plasmids that can be transferred to other bacteria via conjugation and 
that carry all required genes for autonomous replication in the bacterial cells (origin of 
replication). 
Last resort antibiotics: Antibiotics that are used as last options for treatments of infectious 
diseases when alternatives fail due to build-up of high (multiple) resistances to older 
antibiotics in pathogens, or for empiric use, e.g. in intensive care units. 
Lateral gene transfer (transmission): Spread of genes to other bacteria, eventually crossing 
taxonomic borders. 
Mobile genetic element: Mobile DNA structures in bacterial genomes responsible for intra- 
and intergenomic recombinations and/ or lateral transmission. Integrons, insertion (IS) 
elements, transposons, integrative conjugative elements (ICEs), phages and plasmids are 
mobile genetic elements. 
Mobilizable plasmid: Conjugative plasmids that are transmitted with the help of another 
(self-transmissible) plasmid to other bacteria. 
Self-transmissible plasmid: plasmid containing the complete set of genes that is required for 
transmission to other bacteria. 
Transformation: Uptake of extracellular DNA by the cell, in the form of ‘naked’ DNA (i.e. 
unprotected by a cell wall or membrane), from its local environment. 
Transduction: Transmission of foreign DNA from donor to recipient cells via 
bacteriophages. 
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ARG  Antibiotic resistance gene 
AME  Aminoglycoside-modifying enzyme 
COGEM Commissie Genetische Modificatie 
ICE  Integrative conjugative element 
LGT  Lateral gene transfer 
LRA  Last resort antibiotic 
MGE  Mobile genetic element 
MIC  Minimal inhibitory concentration 
MRSA methicillin-resistant Staphylococcus aureus 
PMQR plasmid-mediated quinolone resistances 
ST  Sequence type 
WHO  World Health Organization  
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Voorwoord bij de resultaten van het COGEM project “Transmissie van 
antibioticumresistentie via mobiele genetische elementen”.  
Na de eerste introductie van antibiotica werd het voorkomen van resistentie tegen deze 
belangrijke geneesmiddelen bij bacteriesoorten al snel onderkend. Infecties die aanvankelijk 
effectief konden worden bestreden, bleken niet meer te reageren op antimicrobiële therapie, 
waardoor het risico op complicaties en sterfte weer toenam. De noodzaak ontstond om nieuwe 
antibiotica te ontdekken of oudere middelen te modificeren zodat de kans op onwerkzaamheid 
door resistentie zou verminderen. Aanvankelijk werden hiermee grote successen geboekt, 
maar telkens bleken enige tijd na introductie van een nieuw antibioticum bacteriën 
eigenschappen te ontwikkelen, waardoor zij toch weer resistent werden. Door toenemend 
gebruik van antibiotica bleek, met name in ziekenhuizen, maar ook daarbuiten, het 
resistentieprobleem in omvang toe te nemen.  
Opgemerkt dient te worden dat antibioticumresistentie ook voorkomt in microorganismen in 
complexe ecosystemen, zoals in de bodem, waar van nature antibioticaproducerende 
bacteriën, gevoelige micro-organismen en schimmels in een ecologische balans voorkomen. 
In de jaren zestig is, in eerste instantie door onderzoek in Japan, gebleken dat de genetische 
basis van resistentie niet alleen immobiel in de bacteriecel aanwezig is, maar dat deze zich 
ook kan bevinden op mobiele elementen. Deze mobiele elementen kunnen overgedragen 
worden naar bacteriestammen van de eigen soort en onder bepaalde voorwaarden zelfs aan 
andere soorten.  
Wanneer een schadelijke ziekteverwekker beschikt over een verzameling van genen die 
coderen voor verschillende resistentiemechanismen, worden de mogelijkheden om een 
infectie te behandelen, verkleind en in het ergste geval onmogelijk. We spreken dan van een 
multiresistente ziekteverwekker. Bevinden de resistentiegenen zich ook nog in mobiele 
elementen, dan is er aanzienlijk risico dat onder de selectieve druk van antibiotica, met name 
in zorginstellingen, multiresistente bacteriën zich verspreiden en andere mensen en/of dieren 
besmetten.  
Antibioticumresistentiegenen die de bestrijding van ziekteverwekkers in gevaar brengen, 
worden in de Regeling ggo bestempeld als een 'schadelijk genproduct'. De aanwezigheid van 
dergelijke antibioticumresistentiegenen in bacteriën waar ggo-werkzaamheden mee 
uitgevoerd worden, zou een reden kunnen zijn om deze werkzaamheden op een 
inperkingsniveau met strenge inperkingsmaatregelen in te schalen.  
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Eind 2017 is de COGEM gevraagd of de aanwezigheid van een antibioticumresistentiegen 
tegen vancomycine op een bacterieel plasmide tot een hogere inschaling van de betreffende 
bacterie zou moeten leiden.  Om deze vraag te kunnen beantwoorden, heeft de COGEM 
opdracht gegeven tot een literatuuronderzoek naar de overdracht van 
antibioticumresistentiegenen die op mobiele elementen (zoals plasmiden) zijn gelegen.  
Voor het uitvoeren van dit literatuuronderzoek is een beroep gedaan op de wetenschappelijke 
expertise van Dr. Leo van Overbeek. De begeleidingscommissie is samengesteld uit Prof. Dr. 
Ir. Jan Dirk van Elsas, Dr. Ir. Marjan Bovers, Dr. Ad Fluit en mijzelf. Het onderzoek is gestart 
in augustus 2018 en voltooid in maart 2019. 
De hoeveelheid publicaties over antibioticumresistentie in de internationale literatuur loopt in 
de honderdduizenden. De auteur van het rapport heeft de zeer grote hoeveelheid publicaties 
na zorgvuldige selectie binnen een redelijke tijd geanalyseerd op informatie die van belang is 
voor de beantwoording van de onderzoeksvraag. De begeleidingscommissie is zich bewust 
van de tijdelijke houdbaarheid, omdat – ondanks dat hoofdzaken wetenschappelijk wel vast 
staan - de gedetailleerde wetenschappelijke kennis en de praktische mogelijkheden op dit 
specifieke gebied aan snelle veranderingen onderhevig zijn. 
 
 
Prof. Dr. John Degener 
(voorzitter begeleidingscommissie) 
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Samenvatting  
 
Antibioticum resistenties in bacteriën kunnen ‘intrinsiek’ zijn, dat wil zeggen dat het 
aangrijpingspunt van het antibioticum ontbreekt in de cel of dat het antibioticum het 
aangrijpingspunt in de cel niet kan bereiken, of ‘verkregen’, en dan is de resistentie 
veroorzaakt door mutaties in het genoom of overgedragen vanuit andere bacteriën. Met het 
oog op de risico’s zijn alleen overdraagbare antibioticumresistentiegenen relevant in de 
context van dit rapport. Mobiele genetische elementen (MGEs) spelen een belangrijke rol bij 
de overdracht van genen die resistenties veroorzaken tegen antibiotica. Eventuele associatie 
van antibioticumresistentiegenen (ARGs) met MGEs in elke bacteriesoort duidt op het feit dat 
deze ARGs via  laterale genoverdracht (LGO) zijn verkregen. Het doel van dit rapport is dan 
ook om aspecten aan te duiden die relevant zijn bij laterale overdracht van ARGs, met name 
van genen die betrokken zijn bij resistenties tegen laatste redmiddel antibiotica (LRA), en de 
MGEs waarop deze genen zijn gelokaliseerd in bacteriële genomen met de mogelijkheden tot 
LGO in het laboratorium.  
De wereldgezondheidsorganisatie (WHO) lijst van kritisch relevante antimicrobiële middelen 
(https://www.who.int/foodsafety/areas_work/antimicrobial-resistance/cia/en/) is in dit rapport 
gebruikt als richtlijn om het begrip LRA te definiëren. Deze groep van LRA omvat derde, 
vierde en vijfde generaties van cefalosporinen en verder carbapenems, glycopeptiden, 
macroliden en ketoliden, polymyxines, quinolonen, aminoglycosiden, ansamycinen, 
glycylcyclines en aminomethylcyclines, lipopeptiden en oxazolidinonen. De meeste aandacht 
in dit rapport is gericht op de meest recent ontwikkelde en goedgekeurde agentia binnen 
iedere antimicrobiële klasse, en in mindere mate op de ‘oudere’ antimicrobiële middelen die 
al sinds tientallen jaren worden voorgeschreven voor medische en diergeneeskundige 
toepassingen. Een “semi-systematische” literatuurzoekopdracht is uitgevoerd waarbij er in 
eerste instantie via automatische zoekopdrachten referenties zijn verzameld uit 
literatuurdatabestanden, waarna met de hand verder is geselecteerd op basis van relevantie 
binnen de kaderstelling van dit rapport. De zoekopdracht werd uitgevoerd in vijf 
verschillende literatuurdatabestanden en omvatte de termen ‘ antibiotic resistance’ alleen, of 
in combinatie met ‘mobilome’, ‘resistome’, ‘microbiome’, ‘mobile genetic element’, 
‘pangenome’, ‘gene’, ‘self-transmissible’ en/ of ‘host range’. De geselecteerde referenties zijn 
vervolgens gebruikt voor verdere screening op verwijzingen naar ‘last resort antibiotic’. Op 
basis van gegevens uit de aldus geselecteerde referenties bleek dat genen die resistenties 
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veroorzaken tegen LRA, dikwijls gekoppeld zijn aan MGEs in zowel klinische als 
omgevingsbacteriën.  
Deze ARGs zijn vaak afkomstig van andere bacteriën, en zijn verkregen via LGO. De 
diversiteit van MGEs, waarmee deze ARGs gekoppeld zijn, was groot, uiteenlopend van 
verschillende typen integrons (gelokaliseerd op transposons of plasmiden), insertie (IS) 
elementen, transposons, integratieve conjugatieve elementen (ICEs), plasmiden en in enkele 
gevallen ook (pro)fagen. Genen die resistentie veroorzaken tegen LRA blijken in sommige 
gevallen ook gelokaliseerd te zijn op chromosomen. De kans op laterale overdracht van 
chromosomaal gecodeerde ARGs, in afwezigheid van MGEs, wordt als verwaarloosbaar klein 
beschouwd. MGEs spelen een belangrijke rol bij de overdracht van ARGs naar andere 
bacteriesoorten. 
Twee stappen zijn belangrijk bij het mobiliseren en overdraagbaar maken van ARGs, en dat 
zijn: 1) ‘rekrutering’ waarbij resistentiegenen opnieuw worden gerangschikt waardoor deze 
onder controle van alternatieve regulatie systemen komen te vallen, en dat gebeurt 
voornamelijk door (super) integrons, en 2) ‘klustering’ waarbij verschillende resistentiegenen 
tezamen worden gelokaliseerd op hetzelfde genetische element en dat gebeurt voornamelijk 
door integrons, transposons, IS elementen en fagen. Voor LGO zijn de drie genoverdracht 
systemen in bacteriën relevant: 1) conjugatie, 2) transductie en 3) transformatie en alle drie de 
systemen spelen een doorslaggevende rol bij overdracht van ARGs naar andere bacteriën. 
Laterale overdracht van ARGs via conjugatie gebeurt met behulp van plasmiden en/of ICEs, 
via transductie met behulp van fagen en via transformatie door cel opname van niet-
celgebonden (extracellulair of ‘naakt’) chromosomaal, plasmide of faag DNA afkomstig uit 
de omgeving van de cel. Antibioticumselectiedruk speelt een sturende rol bij zowel 
rekrutering en klustering als bij LGO van ARGs. Selectiedruk vindt plaats in de kliniek en 
veehouderij, maar ook in landbouwsystemen en in natuurlijke omgevingen waarin bacteriën 
zich bevinden. ARGs worden in alle omgevingen aangetroffen, zelfs in omgevingen die nog 
niet zijn beïnvloed door menselijke activiteiten (pristine omgevingen) en in dierlijke resten 
ingevroren in permafrost en daterend uit de periode voorafgaand aan het antibioticum-
tijdperk. In sommige gevallen zijn deze ARGs gekoppeld aan MGEs.  
Rekrutering en clustering van ARGs zijn processen die in alle omgevingen onder selectiedruk 
zullen plaatsvinden en waarvan de tijdsduur langdurig is waardoor het onwaarschijnlijk is dat 
deze processen onder een kortstondige experimentele tijdsduur in het laboratorium (of andere 
ingeperkte omstandigheden) zullen plaatsvinden. Laterale overdracht van ARGs met behulp 
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van MGEs vindt ook plaats onder natuurlijke omstandigheden, maar deze processen zijn van 
korte tijdsduur en kunnen wel onder laboratoriumomstandigheden plaatsvinden. Voor het 
inschatten van risico’s op het ontstaan van antibioticum resistente bacteriën is het belangrijk 
om te weten welke soorten ARGs aanwezig zijn in de gebruikte bacteriestammen en of deze 
genen daadwerkelijk gekoppeld zijn aan MGEs in het genoom, of niet. Afhankelijk van het 
type MGE kan er een inschatting worden gemaakt over de mogelijkheid tot overdracht van 
ARGs. In het geval van plasmiden kan de overdrachtsfrequentie hoog zijn, oplopend tot 10 – 
50% van de ontvangende cel populatie. Bij sommige plasmiden is het gastheerbereik ook nog 
eens groot en deze typen van plasmiden (zoals IncP-1 type plasmiden die gekoppeld zijn aan 
colistine resistentiegenen) moeten worden beschouwd als ‘worst case’ met betrekking tot 
overdracht van ARGs. Risico’s op overdracht van ARGs door andere MGEs, zoals fagen, 
transposons en IS elementen, worden lager ingeschat omdat het gastheerbereik smal is (in het 
geval van fagen), of omdat er eerst transpositie naar een andere MGE moet plaatsvinden 
voordat LGO daadwerkelijk kan plaatsvinden (in het geval van transposons en IS elementen). 
Op basis van de criteria gastheerbereik en overdrachtsfrequentie kunnen MGEs worden 
gerangschikt waarbij de kans op overdracht van ARGs op zelfoverdraagbare plasmiden het 
grootst is en op IS elementen en transposons het kleinst.  
 
  
 10 
 
Summary 
 
Antibiotic resistances in bacteria can be ‘intrinsic’, i.e. there is no target for the antibiotic 
substance present or the antibiotic molecule cannot reach the target site in the cell, or 
‘acquired’, meaning that resistance is caused by genomic mutations in the cell or transmitted 
from other bacteria. Only acquired antibiotic resistance genes (ARGs) are relevant within the 
context of this report. Mobile genetic elements (MGEs) play key roles in the transmission of 
genes conferring resistance towards antibiotics. Eventual association of ARGs with MGEs in 
any type of bacterial species would indicate that ARGs were acquired via lateral gene 
transmission (LGT). The aim of the report was to indicate the most relevant aspects in relation 
to LGT of ARGs, especially the ones conferring resistances towards last resort antibiotics 
(LRAs) when associated with MGEs in bacterial genomes, and to define possibilities on 
lateral transmission in the laboratory.  
The WHO list of critically important antimicrobials 
(https://www.who.int/foodsafety/areas_work/antimicrobial-resistance/cia/en/) was used as a 
guideline for defining LRA. This group of antimicrobial compounds encompass third, fourth 
and fifth generations of cephalosporins and carbapenems, glycopeptides, macrolides and 
ketolides, polymyxins, quinolones, aminoglycosides, ansamycins, glycylcyclines and 
aminomethylcyclines, lipopeptides and oxazolidinones. Most attention in this report was on 
the most recently developed and approved agents within each antimicrobial class and, to a 
lesser extent, to the ‘older’ antimicrobials that already have been prescribed for over decades 
for medical and veterinary applications. A semi-systematic literature search (i.e. automatically 
searched in databases and then further selected out by hand on the basis of relevance within 
the framework of the report) in five library databases, was performed, based on the term 
‘antibiotic resistance’ alone, or in combinations with ‘mobilome’, ‘resistome’, ‘microbiome’, 
‘mobile genetic element’, ‘pangenome’, ‘gene’, ‘self-transmissible’ and/ or ‘host range’ as 
search terms. Selected references were then further selected out for the ones that report on 
‘last resort antibiotics’. Based on these reports, it was concluded that many genes conferring 
resistances towards LRAs in both clinically relevant and environmental bacteria were 
associated with MGEs and thus were acquired via LGT from other bacteria. The diversity of 
these MGEs was high and included different types of integrons (located on transposons or 
plasmids), insertion (IS) elements, transposons, integrative conjugative elements (ICEs), 
plasmids and occasionally (pro) phages. Genes conferring resistances towards LRAs were 
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also found to be located on chromosomes, in the absence of MGEs, and chances on lateral 
transmission of these ARGs must considered to be negligible. MGEs are in most cases 
responsible for lateral transmission of ARGs. 
Two steps are important to make ARGs mobile and transmissible and these are: 1) 
‘recruitment’, i.e. gene rearrangement whereby ARGs are brought under alternative 
transcriptional control and this is mainly done by (super) integrons, and 2) ‘clustering’, i.e. 
placement of resistance genes on the same MGE, and this is mainly done by integrons, 
transposable elements and phages. For LGT, the three gene transmission mechanisms in 
bacteria are relevant: 1) conjugation, 2) transformation and 3) transduction and all three 
mechanisms play pivotal roles in lateral transmission of ARGs. Lateral transmission of ARGs 
towards other species via conjugation is done by plasmids and ICEs, via transduction by 
phages, and via transformation by uptake of non-cellular bound (extracellular or ‘naked’) 
chromosomal, plasmid or phage DNA present in the surroundings of the bacterial cell. 
Antibiotic selective pressure is the most important driver behind recruitment and clustering 
steps and LGO, and all these steps take place in clinical and veterinary environments, but also 
in agricultural production systems and in natural environments undisturbed by human 
activities. ARGs can be found in many different environments, including pristine ones, and 
ARGs were also found in animal bodies frozen in permafrost in the period predating the 
antibiotic era. In some cases these ARGs were associated with MGEs.  
Recruitment and clustering of ARGs take place under selective pressure in all 
ecosystems and these are time-consuming processes, unlikely to take place in the short time 
frame realistic for experimentation in the laboratory (or in any other contained facility). 
Transmission of ARGs to other species is a relatively fast process that can occur in the short 
time frame, realistic for experimentation in the laboratory. For risk assessment purposes, it is 
important to know which type of ARGs is present in bacterial strains and whether they are 
associated with MGEs in the bacterial genome, or not. Assessment on the possibility for ARG 
transmission to other bacteria can be performed on the basis of the type of MGE present in the 
bacterial genome. In the case of plasmids, the transfer frequencies can be high to up to 10 – 
50% of the recipient cell population. For some of these plasmids the host range can be broad 
(as in the case of the IncP-1 type of plasmid that was found to be associated with a colistin 
resistance, mcr,  gene) and these plasmids must be considered as ‘worst cases’ with respect to 
lateral transmission of ARGs. Risk on transmission of ARGs with support of other MGEs, 
such as phages, transposons and IS elements, must be considered to be lower than of 
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plasmids, because of the narrow host ranges of these elements (in case of phages) or because 
of the fact that transposition to other MGEs is required as a first step, before LGT actually can 
take place (as is the case for transposons and IS elements). MGEs can be ranked on the basis 
of host range and transfer frequency as criteria, whereby the chance on ARG transmission 
will be highest when located on self-transmissible plasmids and lowest when located on, or 
closely associated with transposons and IS elements. 
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1 Motive, introduction and framework of the report 
 
This literature study was commissioned by the Commissie Genetische Modificatie, (COGEM) 
to evaluate the aspects of presence of resistances to last resort antibiotics (LRAs), such as 
vancomycin, in bacterial strains that are used for genetic modification. Mobilization and 
transfer of genes encoding resistances towards LRAs to clinically relevant bacteria could 
jeopardize the antimicrobial treatment of patients with (serious) infectious diseases. For the 
COGEM it is important to gain a structured understanding on the possibilities and 
circumstances of lateral transmission of genes, encoding resistance to LRAs and present in 
bacterial strains, that are used for genetic modifications to other (pathogenic) micro-
organisms. At this moment, pathogenicity of bacteria to humans, animals and plants is a 
relevant criterion in risk evaluation for experimentation with genetically modified micro-
organisms under confined circumstances, such as in laboratory and large reactor settings. 
Pathogenicity is an argument to upgrade the experimental containment level, under which the 
genetically modified micro-organisms will be applied, to the next higher containment level, 
and the question that will be addressed in this report is: which aspects play a role, from an 
environmental risk assessment perspective, in experimentation under confined conditions, 
such as in the laboratory with  non-pathogenic bacteria that carry ARGs. Pathogenicity is, 
however, a term that is hard to define because it also depends on the health status of the 
patient. Therefore, for bacterial species in clinical contexts the term ‘clinically relevant 
bacteria’ will be further used in this document. 
LRAs do not constitute a well-defined class of antibiotics. The WHO classified 
antibiotics to be ‘medically important antimicrobials’ 
(https://www.who.int/foodsafety/areas_work/antimicrobial-resistance/cia/en/) (last updated 
version was in 2016) on the basis of two criteria: 1) possibility for alternative antimicrobial 
strategy, in case of allergy, toxicity or resistance, and 2) antimicrobial therapy in case of life-
threatening infection. The different classes of medically important antimicrobials were further 
ranked in importance (Anonymus, 2017, WHO list of critically important antimicrobials) and  
the group of  critically important antimicrobials, both of high and of highest priority 
categories, was used as guideline for this report. Thus, the focus will be on the most recently 
developed and approved agents within each antimicrobial class (Table 1), and less attention 
will be  paid to the ‘older’ antimicrobials that are already prescribed for over longer periods in 
time for medical and veterinary use. Not all antimicrobial classes will fit within the context of  
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this report, such as the classes of monobactams, penicillins, phosphonic acids and drugs that 
are only used for the treatment of  mycobacterial diseases, including tuberculosis.  
 ARGs in clinically relevant bacteria can be acquired and mobile genetic elements 
(MGEs) play key roles in the transmission of these genes. Associations between ARGs and 
MGEs occur, however, both in clinically relevant as well as in environmental bacteria and 
therefore the term ‘bacteria’ refers to both groups in this document, unless specifically 
mentioned. Eventual association of genes conferring resistance towards LRAs with MGEs in 
bacteria would imply higher chances on lateral transmission of this group of ARGs to 
clinically relevant bacteria. Association of ARGs with MGEs can be defined as ARGs that are 
physically located on, or located at a proximate distance from MGEs in the bacterial genome. 
Considering this criterion, a list of genes conferring resistances towards LRAs was made by 
making use of a semi-systematic literature search (i.e. automatically searched in databases and 
then further selected out by hand on the basis of relevance within the framework of the report) 
(Supplement Fig. S1). The main focus will be on later generations of existing, and on recently 
approved antibiotics among the different classes of LRAs. Based on most frequently observed 
associations between MGEs and ARGs, a generic model was made describing the different 
steps in clustering and mobilization of ARGs. By making use of this model, individual cases 
can be assessed by weighing the chances on lateral gene transmission (LGT) to other bacteria, 
especially to clinically relevant bacteria, on the basis of presence or absence of associations 
with different types of MGEs. For that purpose different LGT types were defined for 
experimentation with bacteria carrying ARGs associated with MGEs under contained 
(laboratory) circumstances, based on LGT mechanisms (conjugation, transformation and 
transduction). Different criteria were therefore set with respect to lateral transmission 
properties of the genetic element, such as possibilities for self-transmission, transfer 
frequency and bacterial host range.  
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Table 1. Bacterial targets and resistance mechanisms of different LRA classes 
 
 
 
Antibiotic class Bacterial targets Resistance mechanism 
Cephalosporins and 
Carbapenems 
Gram negative bacteria 
(Proteobacteria) 
Inhibition of  cell wall 
synthesis  
   
Glycopeptides Gram positive cocci Inhibition of  cell wall 
synthesis 
   
Macrolides and ketolides Gram positive bacteria 
(some Gram negative) 
Inhibition of protein 
synthesis 
   
Polymyxins Gram negative bacteria 
(Proteobacteria) 
Cell membrane damage 
   
(Fluoro) quinolones Gram positive and Gram 
negative bacteria 
Inhibition of DNA 
replication and transcription 
   
Aminoglycosides Gram negative bacteria 
(Proteobacteria) 
Inhibition of protein 
synthesis 
   
Ansamycins Gram negative and some 
Gram positive bacteria 
Inhibition of DNA 
transcription 
   
Glycylcyclines Gram positive and Gram 
negative bacteria 
Inhibition of protein 
synthesis  
   
Aminomethylcycline Gram positive and some 
Gram negative bacteria 
Inhibition of protein 
synthesis 
   
Lipopeptides Gram positive bacteria Cell membrane 
depolarization 
   
Oxazolidinones Gram positive bacteria Inhibition of protein 
synthesis 
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2 History of antibiotics and emergence of bacteria resistant to antibiotics  
 
The increase of antibiotic resistance in bacterial pathogens is of major concern for the 
antimicrobial treatments involving antibiotics in the combat against infectious diseases in 
humans and companion animals. Since the discovery of penicillin by Alexander Fleming in 
1928, antibiotics are widely used in medical treatments, but later also in food production by 
using antibiotics as livestock feed supplements to improve overall animal health and 
production yields (Ventola, 2015). The first large scale use of antibiotics (penicillin) occurred 
on allied soldiers in 1943 for the treatment of wound infections, mostly caused by 
Staphylococcus species. In about the same time period the first resistance against penicillin 
was already reported. However, new antibiotics soon arrived; tetracycline in 1950, 
erythromycin in 1953, methicillin in 1960, gentamicin in 1967 and vancomycin in 1972 
(Ventola, 2015).  
However, soon after introduction of new antibiotics, resistances against these agents 
also appeared. First was tetracycline resistance observed in Shigella species (1959), later 
followed by methicillin resistance in staphylococci  (1961), erythromycin resistance in 
Streptococcus species (1968) and gentamicin resistance in enterococci and coagulase-negative 
staphylococci (1979).  Next generation antibiotics were developed to extend bacterial activity 
spectra or to cure infections caused by bacteria that possessed resistances against the ‘older’ 
antibiotics. For example, penicillins were replaced by cephalosporins and carbapenems to 
treat infectious diseases caused by pathogens producing enzymes (-lactamases) inactivating 
the ‘older’ -lactam antibiotics, or these older antibiotics were combined with newly 
developed -lactamase inhibitors (e.g. clavulanic acid) in medical treatments. Beta-lactamase 
inhibitor avibactam could  protect antibiotic activities of ceftazidime, ceftaroline and 
aztreonam against different classes of -lactamases (Giani et al., 2016) and therefore these 
agents are still of medical importance.  
Again resistances to later generations of antibiotics appeared and also accumulation of 
(extensive) resistances against different groups of antibiotics (multiple resistances) or even to 
all clinically available antibiotics (pan-resistance) were reported in single bacterial lineages, 
especially in non-fermenting bacteria such as the ones belonging to Pseudomonas and 
Acinetobacter species (Miriagou et al., 2005). The ‘arms race’ against antibiotic resistances 
resulted in recovery and (semi) synthetic design of the latest generations of antibiotics that are 
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under approval, or that were recently approved. Dalbavancin, oritavancin, and telavancin (all 
three semisynthetic lipoglycopeptides), cefiderocol (cephalosporin), colistin (polymyxin), 
daptomycin (lipopeptide), eravacycline and omadacycline (both aminomethylcyclines), 
fidaxomicin (macrocyclic antibiotic), finafloxacin (fluoroquinolone), 8-hydroxyquinoline 
derivatives, plazomicin (aminoglycoside), tedizolid (oxazolidone) and tigecycline 
(glycylcycline) are the last new-coming antibiotic compounds that appeared on the market 
(Macone et al., 2014, Chaudhary, 2016; Mazer-Amirshahi et al., 2017; Lawung et al., 2018).  
Worrying are the high and still increasing percentages reported on antibiotic 
resistances in Gram-negative bacteria, especially resistances against third-generation 
cephalosporins, often in combination with resistances against fluoroquinolones and 
aminoglycosides (Chaudhary, 2016). For Gram-positive bacteria, the increase in resistance 
against methicillin in Staphylococcus aureus (so called methicillin-resistant S. aureus 
[MRSA] ) and vancomycin in enterococci is worrying (Chaudhary, 2016). Among a survey 
over 19 hospitals in the US from 2007 – 2010, percentages vancomycin resistance in 
Enterococcus faecium among 4024 isolates was 87.1%, oxacillin/methicillin resistance in S. 
aureus was 56.8% (more than 23,477 isolates), clindamycin resistance in S. aureus was 
39.7% (21,133 isolates), fluoroquinolones resistance in Pseudomonas aeruginosa was 32.6% 
(10,982 isolates), fluoroquinolones resistance in Escherichia coli was 31.3% (30,715 
isolates), and daptomycin resistance in E. faecium was 3.9% (2,029 isolates) (Edelsberg et al., 
2014). Currently, the status of infectious diseases must be revisited and worldwide reported 
diseases caused by the ESKAPEE group of pathogens (E. faecium, S. aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, P. aeruginosa, Enterobacter spp. and E. coli 
[Partridge et al., 2018]) has become threatening again due to the high antibiotic (multi) 
resistance levels among this group of pathogens. 
 The use of antibiotics is still rising in low and middle income countries, particularly, 
the use of the so-called LRAs such as carbapenems, glycylcyclines, oxazolidinones and 
polymyxins (Klein et al., 2018). Global increase in the use of antibiotics, and especially 
misuse and use in veterinary and agricultural production systems are considered to be the 
main drivers behind increased antibiotic resistances in different groups of bacteria (Stokes and 
Gillings, 2011; Ventola, 2015, Klein et al., 2018; Harmon et al., 2018). However, no 
epidemiological linkage was found in ESBL/ampC genes and plasmids in microbial 
populations from livestock farms and from humans (Dorado-Garcia et al., 2018; Ceccarelli et 
al., 2019). LRAs, such as carbapenems, are reserved for clinical treatments only, whereas 
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other -lactam antibiotics (third and fourth generation cephalosporins, such as ceftiofur, 
cefquinome and cefoperazone), aminoglycosides, colistin and fluoroquinolones (enrofloxacin, 
danofloxacin, difloxacin and marbofloxacin), that are used for antimicrobial treatment of 
humans, can only be used in animals under restricted circumstances in the Netherlands 
(Anonymous, SDa autoriteit Diergeneesmiddelen, 2016). Persistence of antibiotic residues in 
animal faeces can be long, depending on the chemical composition of the antibiotic 
compound (Kyselková et al., 2013; Berendsen et al., 2018). Based on frequency of use and 
persistence, oxytetracycline, doxycycline, flumequine and tilmicosin antibiotics were 
expected to end up in the environment as result of manure applications to arable land. 
Accumulation and persistence of antibiotics in natural ecosystems will lead to selective 
pressure on environmental bacteria resulting in increased resistances in different groups of 
bacteria. 
Applications for recently approved antibiotics are strictly regulated to prevent 
accumulation of antibiotic resistances in pathogens. LRAs cover a diverse group of 
antimicrobials. This list includes carbapenems (ertapenem, doripenem, imepenem, 
meropenem), but also drugs that are new on the market such as tigecycline, colistin and the 
other drugs mentioned before. In fact colistin is an ‘older’ antibiotic (polymyxin E) that 
reappeared on the market as a solution for pathogens that are already resistant to other 
antibiotics (McKenna, 2013; Osei Sekyere, 2016). Glycopeptides, first generation 
vancomycin and teicoplanin, and second generation (semisynthetic) dalbavancin, oritavancin 
and telavancin, also are considered as LRAs (Binda et al., 2014; Marcone et al., 2018). 
Daptomycin is a more recently approved antibiotic that is used for treatment against MRSA 
infections, but also for patients who developed allergies for -lactams (Sabat et al., 2018). 
Resistances against daptomycin are reported, but still rare (Palmer et al., 2011; Bayer et al., 
2013; Sabat et al., 2018). Linezolid was approved by the US Food and Drug administration 
(FDA) in the year 2000 and resistances against this drug are reported for staphylococci and 
enterococci and therefore its use is only approved for antimicrobial treatment of humans only, 
and not for animals (Endimiani et al., 2011, Gu et al., 2012, Kuroda et al., 2018, Tyson et al., 
2018). The introduction of -lactamase inhibitors in new medicine combinations restored 
antibiotic activities of older generations of cephalosporins and therefore these drugs regained 
their status as LRA.   
.  
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3 Mobile genetic elements associated with antibiotic resistance genes 
3.1 Association of ARGs with MGEs 
A list of genes conferring resistances towards LRAs was created based on information from 
literature. Eventual association of these ARGs with MGEs is summarized in Table 2. Based 
on this information, it can be concluded that mobility of ARGs towards (last resort) 
antibiotics commonly is associated with MGEs. Lateral transmission of these ARGs resulted 
in selection for specific strains or even clonal lineages within the same species. The diversity 
of MGEs associated with ARGs is high and ARGs against LRAs were associated with all 
existing types of MGEs, including integrons (only mobile when located on plasmids or 
transposons), insertion elements (IS), transposons, integrative conjugative elements (ICEs), 
plasmids and occasionally (pro) phages. ARGs were also found to be located on 
chromosomes, in the absence of MGEs, within the same strain or clonal lineage, but these 
genes must be regarded to be less mobile in comparison with the ones associated with MGEs. 
The role of these different MGE types in lateral transmission of ARGs will be discussed into 
more details in the next subsections. 
 
3.2 Transfer of antibiotic resistances. 
Two types of genetic transmission routes exist for (antibiotic resistance) genes among 
prokaryotes; vertical and lateral (synonymous for horizontal) gene transmission (Stokes and 
Gillings, 2011).  
Vertical transmission. In vertical gene transmission, genes are transmitted to the next 
generations of cells via DNA replication and cell division. Vertically transmitted ARGs are 
thus spread clonally to succeeding generations. For transmission of ARGs, this type of 
transmission seems to be relevant because it is often the case that variants of ARGs are 
associated with particular sequence types (STs) and clonal lineages as shown for E. coli 
(Chen et al., 2016; Luo et al., 2018) and K. pneumoniae (Yong et al., 2009; Casella et al., 
2018). The toxin-antitoxin gene systems located on plasmids secure vertical transmission of 
plasmids via clonal offspring, because offspring cells lacking the plasmid will be killed by the 
toxin because of degradation of the unstable antitoxin. However, the genetic background of 
the cell line carrying the ARG also will play an important role in the ecological success of the 
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clonal line. For example, in E. faecalis it was shown that one particular strain carrying the 
linezolid resistance gene cfr also carried multiple adhesion properties on its chromosome that 
were presumed to be involved in biofilm formation (Kuroda et al., 2018). The combination of 
chromosomally-encoded biofilm formation genes and transposon Tn6218-borne linezolid 
resistance provides ecological competence properties to this clonal lineage. Two clonal E. coli 
lineages, denoted as A-ST167 and A-ST410 and originating from, respectively, beef and 
turkey meat samples, both produced CTX-M-15 -lactamase and there was a clear link 
between the gene encoding CTX-M-15 -lactamase and IncF plasmids (Irrgang et al., 2017). 
Because both lines were shown to be prevalent among humans, it was assumed that they were 
transmitted to humans via food consumption. The combination of antibiotic resistance and 
ecological properties to survive on meat and to colonize the human intestinal track made both 
lineages ecologically competent under these specific and selective circumstances.  
 Lateral transmission. In lateral transmission events, genes are transferred to cells of 
the same and of other species, thus potentially crossing taxonomic borders even up to the 
kingdom level (Frost et al., 2005). The definition for LGT within the scope of this report is 
taken over from Stokes and Gilling (2011) that defines LGT as “.... the process whereby the 
DNA from one cell is physically transferred from one cell to another without an absolute 
requirement for cell division and the incorporation of that DNA into the recipient’s genome 
such that it can be stably inherited”.  For LGT, the three canonical processes leading to 
genetic spread across (bacterial) species borders are important and these are: 1) conjugation, 
2) transformation and 3) transduction (Frost et al., 2005).  
For conjugation, physical contact between donor and recipient cells is required and 
DNA is transferred via conjugation pili that connect donor with recipient cells during the 
DNA transmission process. DNA of conjugative genetic elements is transferred via these so-
called sex pili that are assembled from proteins encoded from type IV secretion systems. Type 
IV secretion systems are highly conserved DNA signatures in conjugative elements in Gram-
negative bacteria (Frost et al., 2005). Distinction between conjugative plasmids can be made 
between the ones that are self-transmissible and those that are not. This last group of 
conjugative non-self-transmissible, so called mobilisable, plasmids rely on the presence of 
other (self-transmissible) plasmids in the same bacterial cell for conjugation. Many different 
types of MGEs, such as plasmids and ICEs, involved in conjugation are associated with 
ARGs  (Table 2), indicating that conjugation plays an important role in lateral transmission of 
ARGs among bacteria.  
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Transformation is defined as the uptake of extracellular DNA by the cell, in the form 
of ‘naked’ DNA (i.e. unprotected by a cell wall or membrane), from its local environment. 
Therefore DNA uptake, integration into the host cell genome and expression are crucial steps 
in the transformation process. For integration of (intact) plasmid or phage DNA into the host 
bacterial genome, no homology between incoming and host DNA is needed. However for 
integration of chromosomal DNA into the host genome, extensive DNA similarity between 
new incoming and host genome DNA is needed. Homologous recombination leads to 
incorporation of foreign DNA into the host genome and this process is mediated by proteins 
encoded on the host chromosome and occasionally homologues of these genes are located on 
bacteriophage genomes. For transformation, competence of the receiving bacterial cell for 
DNA uptake is needed and nowadays competence has been described in 60 species including 
clinically relevant species such as S. pneumoniae and Acinetobacter baylyi (Domingues et al., 
2012). Like for conjugation, transformation can also lead to drastic changes in the antibiotic 
resistance profiles of the receiving strains (Domingues et al., 2012).  
Transduction is transmission of foreign DNA from donor to recipient cells via 
bacteriophages. Transduction mostly occurs by ‘wrong’ excision of prophage DNA from the 
donor chromosome, allowing incorporation of phage DNA with additional chromosomal 
DNA fragments, into the phage capsid. There are two types of transduction, generalized and 
specific transduction. In generalized transduction, any type of bacterial DNA is incorporated 
into the phage capsid, whereas in specialized transduction a specific set of genes flanking  the 
phage incorporation side on the bacterial chromosome is incorporated into the phage capsid. 
Generalized transduction is a relative rare event whereas specialized transduction occurs more 
often, for example in E. coli by phage λ. ARGs were found to be present in bacteriophage 
DNA pools from environmental samples, including -lactamase Ambler class D, glycopeptide 
and polymyxin resistance genes (Subirats et al., 2016) and the colistin resistance mcr-1 gene 
(Wang et al., 2018a). Relative abundances of ARGs in bacteriophage DNA pools were 
between < 0.001 and 0.26% in the studies of  Subirats et al. (2016) and Wang et al. (2018a). 
Therefore, bacteriophages present in microbial communities, the so-called virome, must be 
considered as potential sources of ARGs, including the ones classified in this report as LRAs 
Lekunberri et al., (2017). However, the host range of the vast majority of phages is limited to 
strains within the same species. 
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3.3 ARG capturing, gene shuffling and formation of gene cassettes  
ARGs evolved from ancestor genes that not necessarily played roles in antibiotic resistances. 
However, at the start of the antibiotic era the modern forms of ARGs evolved from these 
‘ancestor ARGs’ by subsequent mutation events (Garmendia et al., 2012; Perry and Wright 
2013). Most likely ancestral genes of ARGs are millions of years old and some are supposed 
to play important roles in the defence of antibiotic producers in soil habitats as was the case 
for soil-dwelling and vancomycin producing Amycolatopsis orientalis  (Actinobacteria) 
strains (Binda et al., 2014). These ancestral ARGs are presumed to still exist in areas that are 
undisturbed by human activities, such as in bogland in the Austrian Alps (Obermeier, TU 
Graz, unpublished results). The organization of genes involved in antibiotic resistance in 
clinically important bacteria is, however, often different from the ones found in the original 
antibiotic-producing bacteria as for example shown in the vanA operon located on transposon 
Tn1546 (Kohler et al., 2018) (Table 2).  
Gene capture and shuffling of open reading frames into small discrete mobile elements 
often containing integrons, so called gene cassettes, result in reshuffling of ARGs thereby 
bringing ARGs under transcriptional control of strong promoters. Integrons play pivotal roles 
in chromosomal gene arrangement processes in different bacterial phyla and therefore are 
important in the rapid adaptation of bacteria to environmental changes (Rowe-Magnus and 
Mazel, 2002). Integrons are ancient structures in bacteria, predating the antibiotic era and 
evolved from ancestral structures named ‘super-integrons’. Most likely super-integrons act as 
substrates in the formation of the more modern forms of integrons by capturing resistance 
loci. This was followed by integrating them into mobile and high copy number plasmids 
(Rowe-Magnus and Mazel, 2002). Thereby, promoterless open reading frames are circularised 
and integrated, with the help of an integron (intI)-encoded integrase, into specific attachment 
(attC) sites located elsewhere on the genome and this can be the bacterial chromosome, but 
can also be other genetic elements such as other integrons, transposons, plasmids or (pro) 
phages (Gillings et al., 2015). Open reading frames located on these circularised DNA 
fragments are placed in an operon under the transcriptional control of two promotors (Pc or 
P1 and P2) located on the integron (Rowe-Magnus and Mazel, 2002; van Hoek et al., 2011; 
Partridge et al., 2018). Sometimes, open reading frames are integrated upstream of (strong) 
promoter regions in integrons and these genes will not be expressed. Bacterial strains carrying 
non-transcribed open reading frames will be identified as antibiotic sensitive upon phenotypic 
screening for antibiotic resistance, whereas the structural part of the gene still can be present 
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in the bacterial genome (Rowe-Magnus and Mazel, 2002; Partridge et al., 2018). This might 
be of relevance in case genomic rearrangements in bacterial cells lead to reshuffling of these 
non-transcribed regions, bringing them under the control of alternative, host-controlled, 
promoter regions.  
Integrons thus did not evolve during the antibiotic era, but selective pressure conferred 
by medical and veterinary use of antibiotics accelerated the evolution of integron formation 
carrying (multiple) antibiotic resistance cassettes (Gillings et al., 2015). All genes are co-
expressed in multi-resistance integrons leading to co-selection for antibiotic resistances or to 
genes conferring resistances towards heavy metals and disinfecting agents (quaternary 
ammonium compounds) (Gillings et al., 2015). Nowadays at least five classes of integrons are 
defined of which some are linked to transposable elements, such as integron class 1 to Tn21 
and integron class 2 to Tn7 (Rowe-Magnus and Mazel, 2002; Stokes and Gillings, 2011; 
Partridge et al., 2018).   
 
3.4 Transposable elements and plasmids  
Many different families of insertional (IS) and transposable elements are nowadays 
identified and described in literature and often these genetic elements are specific for different 
groups of Gram-positive and Gram-negative bacteria (Partridge et al., 2018). However, in 
general, transposable elements can be distinguished into the ones that can only integrate into 
new locations in the bacterial genome, or that carry all required genes for conjugative transfer 
in their origin of transfer regions (oriT), the so called ICEs (sometimes also named 
conjugative transposons) (Hall et al., 2017; Partridge et al., 2018). Transposable elements 
such as IS elements and transposons are discrete DNA fragments that duplicate, or that excise 
from old, and integrate into new locations in the bacterial genome and these new locations can 
be the bacterial chromosome, or any other MGE present in the bacterial cell such as plasmids 
or other transposable elements (Zhang et al., 2017; Partridge et al., 2018). 
Plasmids are autonomously replicating DNA fragments in bacterial cells and most 
often these fragments are circular, but sometimes linear. Plasmids consist of so called back 
bone (core) genes, e.g. housekeeping genes that are responsible for maintenance in the cell 
(e.g replication, toxin-antitoxin production and copy number control), and accessory genes, 
i.e. genes that are not necessarily important for maintenance in the bacterial cell, but rather 
confer additional ecological fitness to the host, such as ARGs (van Hoek et al., 2011). 
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Accessory genes are acquired via genetic transfer and recombination events. Different groups 
of plasmids are described (van Hoek et al., 2011; Partridge et al, 2018) based on structural 
differences in backbone genes. In general, plasmids are distinguished on the basis of their 
compatibility with other plasmids in the same bacterial host. Plasmids incompatible in the 
same host belong to the same incompatibility (Inc) group and thus far 26 different 
compatibility groups have been described for Enterobacteriaceae, 14 for Pseudomonads and 
18 for Gram-positive, mainly enterococci and staphylococci, species (Frost et al., 2005). 
Molecular sizes (mainly determined by their accessory gene load), transmission frequencies 
and recipient host ranges are typical features for plasmids, and plasmids substantially can 
differ from each other, even within the same Inc group.  
As mentioned before, plasmids can be distinguished into the groups of conjugative 
and non-conjugative plasmids; i.e. plasmids that can be transferred to other bacteria via 
conjugation, carrying their own origin of transfer (oriT), and those that cannot. Among the 
group of conjugative plasmids there are the plasmids that are self-transmissible; i.e. 
containing the complete set of genes that is required for transmission to other bacteria, known 
as tra genes, and those that lack these tra genes and that are unable to transfer themselves to 
other bacteria, but that can rely on transfer functions provided from other plasmids in trans. 
Conjugative plasmids that are transmitted with the help of self-transmissible plasmids are 
mobilizable plasmids. For transfer of mobilizable plasmids, three parent cells are needed, the 
recipient and two donor cells separately hosting a mobilizable or a self-transmissible plasmid. 
The IncQ type of plasmids belong to the group of mobilizable plasmids and the host range of 
this group of plasmids is extensive conferring large promiscuity to these type of plasmids. 
IncP (especially InP-1) and PromA (Heuer and Smalla, 2012) type of plasmids are examples 
of self-transmissible plasmids and these plasmids were found in soil environments where they 
showed the remarkable capacity to mobilize or retromobilize IncQ plasmids (Heuer et al., 
2002 and van Overbeek et al., 2002). Plasmids can further be distinguished in host range sizes 
and IncF, IncH and IncI type of plasmids are generally regarded as narrow host range, 
whereas IncN, IncP and IncW as broad host range type of plasmids (Suzuki et al., 2010). 
Conjugative plasmids and ICEs are the most important vehicles for lateral transmission of 
ARGs across the bacterial phylogeny spectrum, occasionally crossing kingdom barriers. The 
main difference between ICEs and conjugative plasmids is that conjugative plasmids carry all 
required genes for autonomous replication in the bacterial cells (origin of replication), 
whereas ICEs solely depend on chromosomal replication (van Hoek et al., 2011; Hall et al., 
2017; Partridge et al., 2018). 
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Many different types of plasmids can be present within closely related bacterial strains 
as was the case for the  E. coli ST131 lineage. This lineage revealed the presence of 39 
different plasmids classified on the basis of different properties such as Inc type and on 
protein sequences translated from plasmid backbone genes (Lanza et al., 2014). Of these 39 
plasmids, 11 were identified as IncF2 plasmids, whereas the others were identified as IncN, 
I1/K/BO, I2, A/C and X. Additionally, many cryptic plasmids were found that could not be 
further identified because the open reading frames on these plasmids had not been annotated 
yet. Within the largest group of identified plasmids, the IncF2 plasmids, carbapenem 
resistance genes blaKPC and blaNDM were present. The presence of such a wide diversity of 
plasmids within the same single lineage of E. coli, the so called plasmidome, indicates that 
many different plasmids may occur in the same bacterial strain including hitherto unidentified 
plasmids. This is an important message within the context of the report because it indicates 
that lateral transmission of ARGs associated with MGEs in bacterial strains will remain 
unpredictable, especially when genomic (plasmidome) data are not available. For example, 
the clustering of blaNDM-5 and mcr-1 genes, conferring resistances to, respectively, 
carbapenems and colistin, were both located on the same hybrid IncX3-X4 plasmid in E. coli, 
that most likely resulted from fusion of two separate plasmids that co-occurred in the same 
cell (Sun et al., 2016). Co-location on the same single plasmid lead in co-transfer of antibiotic 
resistance loci, with transfer frequencies of between 4 – 7 x 10-5 per recipient cell. With these 
frequencies, lateral transfer of clustered carbapenem/colistin resistances are realistic in 
infections of humans, where bacterial cell densities in pus can reach numbers of 108 per ml or 
higher.  
 
 3.5 The role of biofilms in lateral gene transfer of antibiotic resistances and recovery of 
antibiotic resistances from uncultured bacteria. 
LGT via conjugation, transduction and transformation takes places in all microbial 
environments. However, the circumstances under which these gene transfer events take place 
may differ for each of the three gene transfer mechanisms. For a long time, bacterial 
attachment to solid phases was considered to be prerequisite for conjugation, although the 
concept of conjugation also taking place between bacterial cells living in planktonic stages 
became more recently accepted (Frost et al., 2005; Lim et al., 2017). However, LGT is 
commonly associated with the formation of (mixed) microbial biofilms in diverse ecosystems 
(Hannan et al., 2010; van Overbeek and Saikkonen, 2016; Lim et al., 2017).  
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Early biofilm formation of E. faecium led to upregulation of 177 genes of which many 
were involved in bacterial cell adherence, plasmid replication and LGT (Lim et al., 2017). 
Also, expression of tetC was upregulated leading to enhanced ribosomal protection against 
tetracyclines which appeared to be relevant in biofilm formation because expression of the 
ribosomal genes was downregulated at the initial stage of biofilm formation. This observation 
coincides with the general observation of high resistance of bacterial cells present in (mixed) 
biofilms towards deleterious agents, such as antibiotics. However, antibiotic resistance is also 
subscribed to the presence of inactive cell forms in biofilms as many bacterial cells in 
biofilms are in a metabolically inactive state. The co-occurrence of chromosomally-encoded 
biofilm formation genes and a transposon Tn6218-borne linezolid resistance in E. faecalis 
isolate KUB3006 (Kuroda et al., 2018) are suggestive for the importance of biofilm formation 
for lateral transfer of ARGs. In a mixed oral microbial community growing as biofilm, the 
transmission of transposon Tn916 loaded with a tetracycline resistance gene was observed 
between Veillonella dispar, acting as donor, to Streptococcus spp., acting as recipients 
(Hannan et al., 2010). Many bacteria in natural ecosystems live as microbial consortia in 
biofilms (Flemming and Wingender, 2010) and the role of biofilms in lateral gene 
transmission via broad-host range plasmids is a rather unexplored phenomena in science to 
date (Klümper et al., 2014).   
 Exploration of bacterial genes in general (metagenomics), or of ARGs 
(resistomics) or MGEs (mobilomics) in specific, among uncultured bacteria via next 
generation sequencing is an upcoming field in microbiological sciences (Frost et al., 2005). 
Different classes of -lactamase genes were found in human gut microbiomes, even from 
individuals that never had been exposed to antibiotics in their lives before (Garmendia et al., 
2012). There are thus strong indications that resistances towards clinically relevant 
antibiotics, including some that are classified as LRA such as vancomycin, are linked to 
environmental resistomes. This altogether makes clear that ARGs commonly are present in all 
natural environments (Heuer et al., 2002; van Overbeek et al., 2002) and that occasionally 
environmental habitats are the sources of ARGs that are commonly found in clinically 
relevant bacteria. Resistome analyses on pan genomes of clinically important pathogens may 
become a new diagnostic tool for the recovery of genes involved in resistances against 
recently approved antibiotics (Kruse et al., 2014; Liu et al., 2016; Sabat et al., 2018). 
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3.6 A generic model for lateral transfer of ARGs and the role of selective pressure 
ARGs originate from natural environments (soil) where they protect antibiotic producers from 
their own toxic products. A three-step generic model provides insight in mobilization and 
lateral transmission of  ARGs under (antibiotic) selective pressure. The first step is 
recruitment of ARGs which is mainly done by (super) integrons as shown before. The second 
step is clustering of all genes required for cellular protection against antibiotics, inactivation 
of antibiotics or for pumping antibiotics out of bacterial cells, but also for clustering of 
multiple antibiotic resistance pathways into resistance islands and this is mainly done by 
integrons, transposable elements and phages. The third step is the transmission of  ARGs or 
resistance islands towards other species and that can occur via conjugative mobile elements 
(conjugation), via DNA from lysed cells (transformation) or via bacteriophages 
(transduction). These steps are presented in Fig. 1. ARGs in environmental and clinically 
relevant strains that are acquired via LGT are always associated with MGEs. For example, in  
Desulfitobacterium hafniense (Kruse et al., 2014), the clustering of all genes responsible for 
vancomycin resistance (step 2 in Fig 1)  appeared to be incomplete. The vanH homologue was 
located outside the vanI operon, making lateral transmission of the complete and functional 
operon into an unlikely event.  
 Important is the role of selective pressure in recruitment, clustering and lateral 
transmission of ARGs (Fig. 1). As shown before, selective pressure is the most important 
driver behind all steps involved in lateral transmission of ARGs. Other factors influencing 
LGT are factors related to plasmid type such as, self-transmissibility, transfer rate and host 
range, but also environmental factors such as local nutrient status (high nutrient availability 
stimulate microbial activities including LGT), cell density, attachment to solid surfaces and/ 
or presence of biofilms. Selective pressure takes place in clinical and veterinary environments 
where antibiotics are used, but can also take place in agricultural and natural settings, e.g. 
upon manure applications (Kyselková et al., 2013; Berendsen et al., 2018) and wastewater 
discharges (Adamczuk and Dziewit, 2017; Khan et al., 2018). Relevant in this aspect is the 
co-selection for ARGs when multiple resistance genes are clustered into genomic islands. 
Selective pressure by a single antibiotic, heavy metal or disinfecting agent can already lead to 
co-selection and lateral transmission of many other resistances, including the ones that are 
classified as LRAs, as was the case for colistin and carbapenem resistance genes that were co-
located on the same (hybrid) plasmid (Sun et al., 2016). Relevant in this aspect is also that 
open reading frames of ARGs in the recruitment and/or clustering steps are not always 
 28 
 
brought under transcriptional control of a (strong) promoter as shown before. Unexpressed 
ARGs in bacterial genomes will be missed by phenotypic selection, but can become 
controlled by an alternative promoter in later offspring upon genomic rearrangements, e.g. via 
transpositions.  
 
Fig. 1. Schematic presentation in the order of events of recruitment, clustering and lateral 
transmission of ARGs in clinical and non-clinical environments under antibiotic selective 
pressure.  
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Table 2. Antibiotic resistance classes and antibiotic resistance genes/ operons associated with 
MGEs prioritized in accordance with the WHO list of critically important antimicrobials 
(2016 version available on internet: 
https://www.who.int/foodsafety/areas_work/antimicrobial-resistance/cia/en/). 
 
Antimicrobial class 
(antibiotics) and 
ARGs/ operons* 
Associated MGEs References 
Cephalosporins and Carbapenems (meropenem, imepenem, ertapenem, doripenem) 
blaKPC ISCR2, ISCR3, IS26, Tn3, Tn1721, 
Tn4401,Tn5393 and IncFII, FIA, FIB, 
I2, A/C, N, X, R, P, U, W, W, L/M and 
ColE plasmids 
Yigit et al (2003), Mathers et al., (2011), 
Chen et al (2014); Bi et al (2015), 
Cerdeira et al. (2017), Luo et al (2018), 
Casella et al (2018)  
blaIMP class 1 and 3 integrons, Tn21, Tn5051, 
and Inc A/C, IncHI2, Inc L/M, IncU 
plasmids 
Poirel and Nordmann (2006), Caratolli 
(2009), Walsh  (2010), Potter et al 
(2016), Luo et al (2018), Ahmad et al. 
(2018)  
blaNDM Class 1 integron, IS26, Tn3, Tn125, 
Tn300, and IncF, IncFII, IncR, IncX3 
and undetermined plasmids 
Yong et al. (2009), Miriagou et al. 
(2010), Walsh  (2010), Bush (2013), 
Potter et al.  (2016), Luo et al (2018) 
blaVIM Class 1 (complex) integrons, Tn402, 
Tn5090 and Inc A/C,  IncFI/II, Inc 
HI2, IncI1, Inc L/M and IncN, IncW 
plasmids 
Miriagou et al. (2005), Caratolli (2009), 
Walsh (2010), Potter et al. (2016), 
Ahmad et al. (2018)  
blaOXA IS1999, ISAba1, ISAba2, 
ISAba3,Tn2006,  
 
Poirel and Nordmann (2006), Walther-
Rasmussen and Høiby (2006), Miriagou 
et al (2010), Walsh (2010),  
Glycopeptides (vancomycin, teicoplanin, televancin, dalbavancin, itavancin) 
vanA* Tn1546, IncI8 plasmids Hegstad et al., (2010), Binda et al. 
(2014), Kohler et al., 2018, Marcone et 
al., (2018), Partridge et al., 2018),  
vanB* Tn1549, Tn5382-like conjugative 
transposons (ICEs), pCF10-like 
plasmid  
 
Hegstad et al., (2010), Binda et al. 
(2014), Marcone et al., (2018), Partridge 
et al., 2018) 
vanC* chromosome Hegstad et al., (2010), Binda et al. 
(2018) 
vanD* chromosome Hegstad et al., (2010), Binda et al. 
(2018) 
vanE* chromosome Hegstad et al., (2010), Binda et al. 
(2018) 
vanG* chromosome/ ICE Hegstad et al., (2010), Binda et al. 
(2018) 
vanI* chromosome Kruse et al. (2014) 
vanL* chromosome Hegstad et al., (2010), Binda et al. 
(2018) 
vanM* chromosome/ plasmid Binda et al. (2018) 
vanN* plasmid Hegstad et al. (2010), Binda et al. (2018) 
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Antimicrobial class 
(antibiotics) and 
ARGs/ operons 
Associated MGEs References 
Macrolides and ketolides (erythromycin, clarithromycin, azithromycin, fidaxomycin) 
erm A,B, C, T, Y genomic islands, transposons, Tn5253-
like composite ICE, plasmids, phage 
(ΦJN4341-pro) 
Chaffanel et al. (2015), Chancey et 
al.(2015), Sugimoto et al. (2017), Feßler 
et al. (2018) 
msr plasmids Feßler et al. (2018) 
mef (A/E)/ C MEGA element, transposons 
Tn916 composite transposons, ICEst3, 
other ICEs and IncA/C plasmids 
Chaffanel et al. (2015), Chancey et 
al.(2015), Sugimoto et al. (2017), Feßler 
et al. (2018)  
mphG plasmid Sugimoto et al. (2017), Feßler et al. 
(2018) 
ere plasmid Feßler et al. (2018) 
Polymyxins (colistin) 
mcr family IncP-1, IncFII, IncH, IncHI1, IncX4, 
IncI2 plasmids 
 
Caniaux et al. (2017), Cannatelli et al. 
(2018), Li et al (2018) 
 
pmrAB,C,F; lpxA,C,D; 
mgrB 
chromosome, interruption by ISAba11 
 
Jaidane et al. (2015), Lean et al. (2015), 
Caniaux et al. (2017), Cannatelli et al. 
(2018), Lomonaco et al. (2018) 
 
(Fluoro) quinolones (ciprofloxacin, nonfloxacin, enrofloxacin and levofloxacin) 
qnr family SulA integron, IS2, IS26, ISEcI2Tn3, 
Inc A/C, H12, F, FII, L/M, N, R, Q, U, 
I1, X2, ColE1 plasmids and phages 
Robicsek et al., 2006, Poirel et al., 2008, 
Strahilevitz et al., 2009, Karah et al., 
2010, Rodríguez-Martínez et al., 2016 
aac (6')-1b-cr Inc FII, R and N plasmids Poirel et al., 2008, Karah et al., 2010, 
Rodríguez-Martínez et al., 2016 
qepA,  IS29, plasmids Poirel et al., 2008, Rodríguez-Martínez 
et al., 2016 
oqxAB IS26, Tn3, IncX1, HI2, and F plasmids Strahilevitz et al., 2009 
qacBIII FIA, FIB and FII plasmids Strahilevitz et al., 2009 
gyrA, parC, rfaD/E chromosomal Rodríguez-Martínez et al., 2016 
Aminoglycosides (plazomicin) 
16 S rRNA transferase,  chromosomal Cox et al., (2018) 
aac(2')-Ia,  
aph(2")-IVa 
plasmids  
Ansamycins (kanglemycin A) 
No resistance  Mosaei et al. (2018) 
Glycylcyclines (tigecycline) 
acrA/B chromosome Huang et al. (2017) 
ramA, rarA chromosome 
 
Cha et al. (2018) 
ompF chromosome Huang et al. (2017) 
oprD chromosome Liu et al. (2016) 
rpsJ chromosome Liu et al. (2016) 
Aminomethylcycline (omadacycline) 
no resistance  Macone et al. (2014) 
Lipopeptides (daptomycin) 
mpfR chromosome Bayer et al. (2013), Tran et al. (2015), 
Sabat et al. (2018) 
 
Oxazolidinones (linezolid) 
cfr family, optrA, 
poxtA 
Tn6218-like and different 
(unidentified) plasmids 
Endimiani et al. (2011), Gu et al. (2014), 
Kuroda et al. (2018), Tyson et al (2018) 
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4 Mobility of  genes conferring  resistances to LRAs 
4.1 Association of genes conferring resistance to LRAs with MGEs 
Eventual association of genes conferring resistance to LRAs with MGEs will be illustrated in 
this section. Lateral transfer plays an important role in transmission of ARGs to other 
bacterial species, including the ones that are of clinical relevance. Association of genes 
conferring resistances to the group of LRAs (as presented in Table 1) with MGEs will be 
described in the next subsections and are summarized in Table 2. 
    
4.2 Cephalosporins and carbapenems 
Third, fourth and fifth generations of cephalosporins and carbapenems are classified as LRAs. 
However, considering the sharp increase in reports on carbapenem resistances over the last 
years, the focus in this document will be mainly on carbapenem resistances. Carbapenems 
belong to the group of -lactam antibiotics that serve as LRAs in treatments of infectious 
diseases caused by bacteria that are resistant to first, second and third-line antibiotics 
(Chaudhary, 2016). Enzymes deactivating -lactams by hydrolysis are named -lactamases 
and carbapenemases are in fact -lactamases capable to inactivate carbapenems. In total at 
least 1150 -lactamases are nowadays known to be located on chromosomes, plasmids and/or 
transposons (van Hoek et al., 2011). Subdivisions can be made based on molecular identity of 
-lactamases (so called Ambler classes; Bush and Jacoby, 2010; van Hoek et al., 2011. Kish, 
2018) or on activity spectra (narrow, moderate, broad and extended spectrum -lactamases 
[van Hoek et al., 2011]). The group of ESBLs confers resistances to penicillin, first, second 
and third generation cephalosporins and aztreonam, but not to carbapenems and are blocked 
in their activities by -lactamase inhibitors (van Hoek et al., 2011). Using the Ambler 
classification, -lactamases are divided over 4 groups (A through D) of which -lactamases 
belonging to Ambler classes A, C and D utilize serine for -lactam hydrolysis, whereas the 
ones belonging to class B use zinc, the so called class B metalloenzymes (Bush and Jacobi, 
2010). Serine carbapenemases are present in Ambler classes A and D and metallo-
carbapenemases in class B2 (Table 2). The most prevalent classes of carbapenemase genes are 
blaKPC (K. pneumoniae  metallo--lactamases), blaIMP (imipenemase metallo--lactamases), 
blaNDM (New Dehli metallo--lactamases), blaVIM (Verona integron-encoded metallo--
lactamases) and blaOXA-48-like (oxacillin carbapenemases) and these are the so called big five 
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group of ESBLs/ carbapenemases. Genetic loci encoding carbapenemases (three in class A, 
four in class D and three in class B2) are commonly located on, or closely associated with 
MGEs, including different classes of integrons and transposons and different incompatibility 
(Inc) groups of plasmids (Table 2). Two loci encoding carbapenemases, blaFRI and blaNMC-A, 
are located on chromosomes of, respectively, Enterobacter cloacae and E. ludwigii strains 
(Potter et al., 2016). Not all carbapenemase resistance phenotypes are conferred by -
lactamase activities, for example mutations in arcAB-tolC efflux pump genes and in ompC, F 
and K porin protein genes exist in enterobacterial species, whereas in P. aeruginosa other 
mutations causing resistance to carbapenems can be found (Potter et al., 2016). These 
mutations are, however, all chromosomally located and therefore not relevant in the context 
of this report. Overall, nearly all genes encoding carbapenemase activities are located on 
MGEs in Gram-negative (often enterobacterial) species (Table 2).  
 
4.3 Glycopeptides 
In 1997 the first report appeared on decreased susceptibility (increased minimal inhibitory 
concentration [MIC] of between 3 – 8 µg/ ml) to vancomycin in a MRSA isolate from Japan 
(Gardete and Tomasz, 2014). The resistance locus of these so-called vancomycin 
intermediate-resistant S. aureus (VISA) group of isolates was not found to be associated with 
MGEs. Later, however in 2002, the first reports appeared on vancomycin resistant S. aureus 
isolates showing MICs of 100 µg/ ml or higher and the resistance loci for this group of 
isolates were linked with transposon Tn1546, containing the vancomycin resistance locus 
acquired from E. faecalis, which was already described in early 1970s (Hegstad et al., 2010; 
Gardete and Tomasz, 2014). The resistance was based on cell wall precursor conversion from 
D-ala-D-ala to D-ala-D-lac, of which the last was less susceptible for the inhibitory activity of 
vancomycin in cell wall synthesis. The vancomycin vanA resistance locus located on 
transposon Tn1546 consisted of an operon with seven genes clustered in three loci, vanXAH, 
vanZY and vanSR (Table 2). The vanXAH cluster of genes, encoding, respectively, a 
dipeptidase, a ligase and a dehydrogenase, was responsible for the cell wall precursor 
conversion from D-ala-D-ala to D-ala-D-lac. Of the other two clusters, vanZY contributed to 
high levels of vancomycin and low levels of teicoplanin resistance, whereas the vanSR cluster 
was responsible for two component cascade signalling (Binda et al., 2014). In total 10 van 
operons (A, B, C, D, R, G, L, M and N) (Binda et al., 2014) and a recently discovered operon 
in D. hafniense, vanI (Kruse et al., 2014), are nowadays described (Table 2). These operons 
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are responsible for different cell wall precursor modifications; expression from vanA, B, D, M 
and I lead to D-ala-D-lac conversions, whereas expression from van C, E, G and L lead to D-
ala-D-ser conversions. Remarkably, for all 10 operons resistance to vancomycin (MICs 
ranging from 2 - >256 µg/ ml) is higher than to teicoplanin (MICs ranging from 0.5 – 512 µg/ 
ml) (Binda et al., 2014). Vancomycin operons A, B, M and N are associated with ICEs, 
transposons and plasmids (Table 2). Therefore, most of the van operons must be considered as 
mobilizable resistance loci present among Gram-positive bacteria of clinical importance, but 
also among commensal Gram-positive species resident in the human gut microbiome. An 
exception is, however, the vanI operon in D. hafniense, which does not contain the vanH 
homologue inside the resistance gene cluster locus (Kruse et al., 2014). The physical location 
of the vanH homologue outside the vanI operon greatly hampers lateral transmission of the 
intact regulon to other (Gram-positive) species and thus lateral transmission of vanI-mediated 
resistance must be considered as negligible.  
 
4.4 Macrolides and ketolides 
Erythromycin, originally isolated from a bacterium, Saccharopolyspora erythreae, became 
clinically available in 1952 for treatment of infections caused by Gram-positive bacteria such 
as Enterococcus, Clostridium difficile, but also by Chlamydia trachomatis. Later in the 1970s 
more acid stable derivatives of erythromycin, named clarithromycin, azithromycin and 
fidaxomycin, came on the market. Resistances have been found among clinically-relevant 
Gram-positive bacterial species such as Staphylococcus spp., Streptococcus spp., especially S. 
pneunomiae and S. salivarius, but also among Gram-negative (aquatic) bacteria such as 
Vibrio, Photobacterium, Pseudoalteromonas and Shewanella spp. (Table 2). Most likely, 
macrolide/ketolide resistant environmental bacteria, such as typical water-borne Shewanella 
species, were the progenitors of the resistant strains found among clinically relevant bacteria. 
Five macrolide resistance gene families have been found to date and all representatives are 
linked to MGEs. The erm family of macrolide resistance genes, all encoding 23S rRNA 
methylase, are linked to plasmids, transposable elements, genomic islands and a phage 
(ΦJN4341-pro). The msr family of resistance genes encode for ABC-F proteins conferring 
ribosomal protection to macrolides and these genes are associated with plasmids. The mef 
(encoding a macrolide cellular efflux pump) family of resistance genes are associated with the 
macrolide genetic assembly (MEGA), that on its turn carries conjugative Tn916 (ICEst3) 
elements. Interesting from this perspective is that Tn916 and derivatives are not able to 
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conjugate between Streptococcus species and because these species are known to be 
proficient for transformation, it seems likely that macrolide resistance acquisition to S. 
pneumoniae occurs via transformation (Chancey et al., 2015). IncA/C type of plasmids also 
carries mef genes and also a second macrolide resistance gene, mphG. This gene belongs to 
the class of mpg resistance genes and its gene product encodes for a macrolide phosphate 
transferase. Besides with IncA/C plasmids, this gene family is also associated with other 
plasmids and ICEs. The last macrolide gene family is ere group of macrolide resistance genes, 
which all encode for a macrolide esterase and this family of genes is commonly associated 
with plasmids. 
 
4.5 Polymyxins 
Colistin is used for antimicrobial treatments of infections caused by multidrug, and in 
particular by carbapenem-resistant Enterobacteriaceae, A. baumannii and P. aeruginosa 
strains and lineages (Caniaux et al., 2017). Colistin (polymyxin E) was reintroduced into 
medical healthcare as LRA to cure patients from infections caused by multi-resistant Gram-
negative pathogens and for prophylaxis for oral and digestive tract decontaminations, in spite 
of its neurotoxic and nephrotoxic effects to humans (Hille et al., 2018). Until recently (2015), 
resistance to colistin was believed to be chromosomally borne until a plasmid-borne 
resistance to colistin, encoded from the mcr-1 locus, was described in E. coli and K. 
pneumoniae strains (Caniaux et al., 2017). The mcr-1 locus encodes a  phosphoethanolamine 
transferase that adds ethanolamine residues to lipopolysaccharides (LPS) present in the outer 
membrane of Gram-negative bacteria thereby neutralizing the positive charge of LPS and thus 
decreasing the affinity of colistin to LPS (Caniaux et al., 2017). Mobilizable mcr-1 genes are 
presumed to originate from livestock where polymyxin was widely applied as supplement in 
cattle feed in the past (Hille et al., 2018). Nowadays eight mcr loci are reported in Gram-
negative bacterial strains (Wang et al., 2018b) and all are associated with plasmids from 
different Inc groups (Table 2), among which a self-transmissible IncP-1 type of plasmid. 
Conjugation experiments with Salmonella enterica serovar Typhimurium and K. pneumoniae 
lineages containing mcr-1 genes revealed high in vitro transmission rates of between 8.2 x 10-
5 – 2.07 x 10-1 per E. coli J53 recipient cell (Saavedra et al., 2017). Besides mobilizable mcr 
genes, other chromosomally-encoded loci are responsible for colistin resistance in A. 
baumannii, P. aeruginosa and Enterobacteriaceae (Table 2). These colistin-resistant 
phenotypes are caused by mutations or insertional inactivation by ISAba1 in 
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lipopolysaccharide biosynthesis (lpxA, C and D), lipid A production (pmrCF) and two 
component transport system genes (pmrAB), and in K. pneumoniae chromosomal mgrB genes 
(Table 2). In spite of the fact that these genes are chromosomally encoded and presumed to be 
immobile, the presence of the ISAba1 element, possibly originating from a plasmid, indicate 
association with a MGE. 
 
4.6 Quinolones   
Nalidixic acid is a fully synthetic quinolone with bactericidal activity against 
Enterobacteriaceae and became clinically available in 1962 (Robicsek et al., 2006). Later 
generations of quinolones, with different additions of fluorine to the quinolone ring, were 
developed and these became available in the 1980s. The group of fluoroquinolones contains, 
amongst some other quinolones, ciprofloxacin, norfloxacin, enrofloxacin and levofloxacin. 
The molecular targets for quinolones in the bacterial cell are DNA gyrase and topoisomerase 
IV. There are different types of chromosomally-encoded resistances known and these 
resistances are based on mutations in the DNA-gyrase (gyrA) and the topoisomerase IV 
(parC) genes, and defects in lipopolysaccharide synthesis (rfaD and rfaE) genes (Table 2). 
Further, orthologues of the qnr gene (qnrA4, 5 and 6) are located on the chromosome of 
Shewanella algae, a bacterial species commonly found in aquatic environments. The qnr 
gene, of which its product confers protection for topoisomerases against quinolones, belongs 
to the group of the so called plasmid-mediated quinolone resistances (PMQRs). Most likely, 
quinolone resistance genes in S. algae strains must be considered as progenitors of PMQRs 
that are nowadays commonly found in many different bacterial species. The PMQRs are 
encoded by different gene families that include the qnr family of genes (qnrA, B, S, C, D and 
VC), aac(6’)-1b-cr (an aminoglycoside modifying enzyme deactivating ciprofloxacin) and 
genes encoding efflux pumps (qepA, oqxAB and qacBIII) (Table 2). All three families are 
associated with MGEs including plasmids of different incompatibility groups (especially with 
a conjugative IncN type of plasmid [Karah et al., 2010]), integrons (class 1), transposable 
elements and phages (mainly qnrA and qnrS). Often quinolone resistance genes are linked to 
other resistance genes such as ampC and bla genes (conferring resistance against ampicillin, 
cephalosporins and carbapenems), and different groups of aminoglycoside resistance genes. 
The aac(6’)-1b-cr-encoded acetyl-transferase confers co-resistance to tobramycin (Rodríguez-
Martínez et al., (2016). The PMQRs are found among Proteobacteria and are most 
prominently present among Enterobacteriaceae. 
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4.7 Aminoglycosides 
Streptomycin, originally isolated from Streptomyces griseus, belongs to the family of 
aminoglycosides. Other aminoglycosides are gentamicin, hygromycin, kanamycin and 
tobramycin and semi-synthetic compounds, amikacin, arbekacin, isepamicin and netilmicin. 
Aminoglycosides display bactericidal activities against aerobic Gram-negative species and 
also to some anaerobic and Gram-positive groups. Large groups of plasmid-mediated 
resistances are known (van Hoek et al., 2011) that can be classified into the three major 
groups of acetyltransferases, nucleotidyltransferases and phosphotransferases (all named 
aminoglycoside-modifying enzymes, AMEs). A different, chromosomally-encoded, 16S 
rRNA methyltransferases group of enzymes modifies the aminoglycoside target site, thus 
making aminoglycosides inactive for antimicrobial treatment. Resistances to aminoglycosides 
are well described in older literature and many of the aminoglycosides are clinically less 
relevant. However, next generations of aminoglycosides still are developed and the latest one 
is plazomycin (Cox et al., 2018; Kish, 2018). Most of the AMEs did not affect plazomycin in 
E. coli with the exception of aac(2’)-1a and aph(2”)-IVa whose gene products decreased the 
potency of the antibiotic compound to a limited extent. However, the presence of the 
chromosomally-located 16S rRNA methyltransferase gene in E. coli completely abolished the 
antimicrobial effectiveness of plazomycin. Clonal variants of chromosomally encoded 
plazomycin resistant E. coli strains will be selected under aminoglycoside pressure in clinics 
and this will lead to further spread of plazomycin resistant bacteria.   
 
4.8 Ansamycins 
Rifamycin binds in the vicinity of the active site of the -subunit of RNA polymerase and is 
blocking RNA elongation sterically. Semi-synthetic antibiotics were derived from rifamycin, 
of which rifampicin is the best known antibiotic compound. Resistances to rifamycin and 
rifampicin occur by spontaneous mutations in the RNA polymerase -subunit making binding 
of both compounds to the RNA polymerase molecule impossible. Resistances to rifampicin 
are chromosomally encoded and spontaneous rifampicin-resistant derivative strains are 
commonly applied in scientific experiments. Rifampicin resistance is present in multi-
resistant Mycobacterium tuberculosis strains, making rifampicin and other (semisynthetic) 
rifamycins non-functional for treatment of tuberculosis. However, a natural compound 
kanglemycin A,  derived from a Nocardia mediterranei var. kanglensis strain, binds to the 
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same target  site on the RNA polymerase as rifampicin, even in Gram-positive bacteria and 
multi-resistant M. tuberculosis strains that were resistant against rifampicin, making 
kanglemycin A a potent agent for suppression of growth of rifampicin resistant bacteria 
(Mosaei et al., 2018). Kanglemycin A and semi-synthetic derivatives of this compound make 
ansamycins effective again for antimicrobial treatment of infections caused by multi-resistant 
M. tuberculosis strains.  
   
4.9 Tetracyclines/ Glycylcyclines/ Aminomethylcyclines  
Widespread resistances exist against the older tetracyclines: tetracycline, doxycycline and  
minocycline. New ‘tetracyclines’ have been developed and recently approved and these 
include glycylcyclines, specifically tigecycline, fluorocyclines, including eravacycline, and 
aminomethylcyclines, including omadacycline. Resistances to tigecycline were reported in 
(carbapenem-resistant) Enterobacter spp., E. coli and A. baumannii strains (Table 2). 
Resistances were all located on chromosomes and no associations with MGEs were reported. 
Resistances were based on point mutations and homologous recombination in efflux pump 
(acrA/B), transcriptional regulator (ramA and rarA), outer membrane (ompF) protein and 
porin (oprD), ribsomal S10 protein (rpsJ), and benzoate degradation genes. Resistance to 
omadacycline officially has not been reported to date (Macone et al., 2014), but increased 
minimal inhibitory concentrations (MIC) for omadacycline has been reported in clinically 
relevant bacteria and often these resistances were correlated with resistances to tetracycline. 
Omadamycin is effective against MRSA and Gram-negative species such as E. coli, H. 
influenzae and K. pneumoniae, even in strains that carry the ‘classical’ tetracycline resistance 
mechanisms such as ribosomal protection and efflux pump determinants.    
 
4.10 Lipopeptides 
Daptomycin, approved as antibiotic by the US Food and Drug Administration in 2003, is used 
as frontline (last resort) agent against MRSA and against methicillin-sensitive S. aureus in 
patients that possess allergies against -lactams (Bayer et al., 2013). The working mechanism 
of daptomycin is distinct from most other antibiotics as it causes rapid depolarization of the 
bacterial cell membrane and ultimately leading to cell death, however without causing cell 
lysis. Chromosomally-borne daptomycin resistances have been reported to date (Table 2). 
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Best described is the multiple peptide resistance factor (mpfR) gene involved in cell wall and 
membrane homeostasis. Comparisons between two clinical S. aureus strains resistant to 
daptomycin and one S. aureus strain susceptible to this antimicrobial agent on the basis of 
whole genome DNA sequence and RNAseq analyses revealed co-expression of core genome 
genes that correlate with daptomycin resistance (Sabat et al., 2018).  
 
4.11 Oxazolidinones 
From 2001 on, linezolid has become an alternative to break vancomycin resistance in 
therapies against (vancomycin-resistant) MRSA in patients with lung diseases and cystic 
fibrosis (Gu et al., 2012). However, one year after its approval, resistances against linezolid 
were already reported, especially in specific clonal types (sequence type [ST] 5) of S. aureus 
(Endimiani et al., 2011; Gu et al., 2012). Resistances to linezolid were caused by mutations in 
the 23S ribosomal RNA binding site, in the L3 and L4 ribosomal proteins responsible in 
peptide translocation and by a plasmid-borne ribosomal methyltransferase encoded from the 
cfr gene (Endimiani et al., 2011; Gu et al., 2012). A variant of the plasmid-borne cfr gene, 
cfrB, was shown to be located on a transposon Tn6218-like element in E. faecalis that was 
99% identical to a homologue present in C. difficile (Kuroda et al., 2018). Further, one 
(optrA) out of two additional linezolid resistance genes, and both conferring protection to 
ribosomal genes, were found to be located on a hitherto unidentified plasmid (Kuroda et al., 
2018). Both cfr and optrA genes were located on plasmids of (vancomycin-resistant) E. 
faecium and E. faecalis strains (Lazaris et al., 2017; Tyson et al., 2018). One plasmid of 73 kb 
in size and some other plasmids present in E. faecium strains, all containing cfr and optrA 
genes, also possessed loci conferring resistance to other antibiotics. One novel plasmid of 8 
kb in size from an MRSA strain contained the cfr gene (Lazaris et al., 2017; Tyson et al., 
2018). This information demonstrates the potential for lateral transmission of linezolid 
resistance genes among Gram-positive species (Table 2).     
  
4.12 Relevance of ARG association with MGEs in the context of this report 
Genes conferring resistance to LRAs commonly are associated with different types of MGEs 
such as integrons, IS elements and transposons, ICEs, phages and different types of plasmids 
as shown in Table 2. There is no preference of these type of ARGs for any MGE in particular. 
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Further, the ICEs, phages and plasmids will have different transfer rates and host ranges, 
which are, in most cases, even unknown and local reigning circumstances (nutrient 
availability, attachment and bacterial incorporation in biofilms) will further influence the 
possibilities for LGT. It is therefore not possible to provide any quantitative prediction on 
ARG transmission via these elements in bacterial strains that are used under contained 
circumstances, for example in the laboratory.  
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5 Conclusions 
 
• Resistances to antibiotics  are common in all natural environments including 
permafrost samples dating from before the antibiotic era and from the ones that thus 
far remained undisturbed by human influences. 
• Recruitment, clustering, mobilization and lateral transmission of ARGs will occur in 
all environments (clinical and natural) under antibiotic selective pressure.  
• Antibiotic pressure selects for antibiotic resistant lineages among bacteria present in 
clinical and non-clinical (e.g. sewage water and manure) environments.   
• Environmental bacterial strains carrying ARGs associated with MGEs are in principle 
always capable to transmit antibiotic resistances to clinically relevant bacterial 
species.  
• ARG recruitment and clustering are long-term processes that take place in the 
environment, but ARG transmission, via conjugation, transformation and transduction, 
are processes that can take place in the short time frame realistic for laboratory work. 
• Chances on lateral transmission of antibiotic resistances in bacterial strains, that are 
not associated with any type of MGE in their genomes, must be considered as 
negligible. 
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6 Recommendations and decision model 
 
For risk assessment analysis (Fig. 2), it is important to know which type of ARGs is present in 
bacterial strains. Preferably, presence of ARGs in bacterial strains must be determined via 
genotypic (full genome sequence analysis) and sometimes phenotypic screening. The most up 
to date list of  ‘critically important antibiotics’ of the WHO (the most up to date list for now is 
the 2016 version) can be taken as guideline for the clinical relevance of ARGs. If resistances 
against critically important antibiotics are present in bacterial strains, then information needs 
to be provided about the localization on the genome (chromosome or on extrachromosomal 
elements such as plasmids and phages) and eventual association with (other) MGEs. In case 
ARGs are associated with MGEs, then there always will be a considerable chance on intra- 
and intergenomic recombination and on lateral transmission of ARGs either via conjugation 
(plasmids or ICEs), transduction (phages) and/ or transformation (under the premises that 
bacteria are naturally competent and, for chromosomal DNA transfer, that there is sufficient 
homology between donor DNA and DNA sequences present in the genome of the receiving 
strain). The decision model shown in Fig. 2 can also be applied for multiple genes conferring 
resistance to one particular class of antibiotics, as is the case for glycopeptide (vancomycin - 
teicoplanin) resistance. All genes responsible for vancomycin - teicoplanin resistance must be 
clustered in a distinct operon on a MGE as is the case with the vanA and vanB operons. This  
was not the case for the vanH homologue, that was located outside the vanI operon in D. 
hafniense (Kruse et al., 2014). In this particular case, lateral transmission of the complete set 
of genes responsible for conferring resistance to glycopeptides must be considered as low.   
MGE types and their relevance in lateral transmission of associated ARGs to other 
bacteria are categorized in Table 3. The classification shown in Table 3 is based on self-
control in transmission of the MGE, (estimated) transfer frequencies and host ranges. The first 
category consists of (conjugative) self-transmissible plasmids, either with narrow (Inc F, H, I) 
or broad host ranges (Inc N, P, W). Transmission by this type of MGE is self-controlled by 
making use of only two parental (donor and recipient) cell types. Transfer frequencies of self-
transmissible plasmids can be very high, to up to 10 – 50% of the recipient cell population 
(Heuer and Smalla, 2012). The second category consists of plasmids that cannot regulate their 
own transmission and that need help from another plasmid present in a distinct donor cell 
population (donor helper cells) for transmission of ARGs, as is the case for the group of 
conjugative but non-self-transmissible (mobilisable) plasmids such as IncQ plasmids. These 
 42 
 
type of plasmids occasionally can have high transfer frequencies and can reach broad species 
spectra, but conjugation of these type of plasmids rely on the presence of a self-transmissible 
plasmid present in a second donor cell population. Expectedly, the frequency in occurrence of 
triparental matings will be lower than of biparental matings with self-transmissible plasmids 
in nature. The reason that plasmids with broad and narrow host ranges are not classified into 
separate categories is because predicted host ranges of particular Inc group of plasmids 
substantially differ from experimentally determined host ranges (Heuer and Smalla, 2012; 
Suzuki et al., 2010), indicating the great uncertainty that still exist on actual host ranges of 
different Inc groups of plasmids. The third category consists of phages and often there is a 
high specificity of phages for their hosts. Transduction frequencies can be high, to up to 10-2  
per recipient cell. The fourth category consists of  ‘naked’ DNA, and for transduction, 
competence for DNA uptake in bacteria is required and also sufficient homology for DNA 
integration in case of extracellular chromosomal DNA fragments, which is not the case for 
plasmid and phage DNA. The fifth category consists of transposons/ IS elements and for 
LGT, transposition events to other MGEs must take place in first instance, before actual 
transmission to other bacteria can occur.  
A ranking on the basis of possibility for transmission of ARGs to other bacteria is 
made in Table 3. Congruent data on frequency of transmission and host range of the MGEs 
where ARGs are located on is only provided in exceptional cases in the literature. Transfer 
frequencies of ARGs located on MGEs can be very high, especially when ARGs are located 
on plasmids. Also, the host range can be broad and IncP-1 type of plasmids commonly confer 
high transfer rates to broad bacterial species spectra and this type of plasmid can be 
considered as a ‘worst case’ in the transmission of ARGs in general. For example, mcr genes 
conferring resistance to colistin was located on an IncP-1 plasmid (Li et al., 2018; Table 2). 
Other MGEs confer lower transmission frequencies to ARGs and also bacterial host ranges 
are narrower. LGT via conjugation (transfer via single or double donor strains), transduction 
and transformation (categories 1 - 4) can occur in relatively short time frames that are realistic 
under confined, laboratory, circumstances (within one to several  hours). Transposition to 
MGEs followed by LGT via other MGEs are distinct processes taking place in sometimes 
different bacterial genomes and therefore the expected time for ARGs to be transmitted via 
transposons/ IS elements to other bacteria will be longer than for the MGEs described in 
categories 1 – 4.  Also, the expected LGT frequencies of transposons/ IS elements 
(transposition frequency to the MGE times transfer frequency of the MGE with transposon to 
other bacteria) will be much lower than for the other LGT types shown in Table 3. Therefore 
 43 
 
LGT category 5 is lowest in ranking, indicating that eventual occurrence of LGT via bacterial 
strains containing ARGs located on transposons or adjacent to IS elements must be expected 
to be very low, although, LGT via these MGEs  cannot  totally be ruled out.  
In summary, contamination of workers with bacterial strains carrying ARGs do not 
directly affect the health status of these individuals. Therefore, antibiotic resistance in bacteria 
must be considered as a ‘hazard’ and not as ‘risk’. Only under specific circumstances where 
ARGs are transmitted to bacteria causing infections in humans, impact on health might be 
expected, in case antibiotic treatment of infections fail. Dissemination of ARGs via 
unintended releases from the contained area (laboratory) to the environment may lead to 
further spread of these ARGs to other bacteria via LGT. However, that these incidental 
releases of bacterial strains carrying ARGs would lead to increased risks for antibiotic 
resistances in clinically relevant bacteria seems unlikely. For dissemination of ARGs to other 
bacteria, antibiotic selection pressure is needed and as long as selective pressure is absent, no 
specific stimulation for growth of antibiotic resistant bacteria can be expected.  
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Table 3. Typing of LGT systems, based on bacterial LGT mechanisms, into separate 
categories dependent on self-control in MGE transmission, transfer frequency and host range.  
 
 
 
LGT 
type 
MGE type Criteria 
1 Self-transmissible 
plasmids, some ICEs 
Biparental conjugation 
Transfer frequency to up to 10 – 50% / recipient cell 
Transfer to broader species spectra 
One single donor strain needed 
No other MGEs needed for transmission 
Time frame for transmission, one – several hours 
2 Mobilisable plasmids,  
some ICEs 
Triparental conjugation 
Transfer frequency to up to 10 – 50% / recipient cell 
Transfer to broader species spectra 
Other plasmid in a separate donor population needed  
Time frame for transmission, one – several hours 
3 Phages Transduction 
Transfer frequency to up 10-2/ recipient cell  
High specificity for host strains, 
Time frame for transmission, one – several hours 
4 ‘Naked’ DNA (in the 
form of chromosomal, 
plasmid or phage 
DNA) 
Transformation 
Competence of the recipient strain needed  
Transfer efficiency depends on DNA type and can be 
up to 1011 transformants/ µg plasmid DNA 
Time frame for transmission, one – several hours 
5 Transposons and IS 
elements 
Transposition  
Transmission to other MGEs (plasmid, ICE, phage)  
required before transmission to other species is 
possible. 
Likely does not fit in time frame for laboratory work 
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Supplementary material  
 
Strategy for bibliographic searches in library databases 
 
For this report, a semi-systematic literature search was performed according to a three-step 
approach (FigS1). Therefore, relevant publications and reports were automatically searched in 
databases and then further selected out by hand on the basis of relevance within the 
framework of the report. In the first step, a literature search was conducted only using the 
term ‘antibiotic resistance’ in titles, abstracts and keywords of all peer-reviewed publications, 
reports and symposium abstracts present in five library databases. Last search was done on 20 
December 2018. These searches resulted in numbers of between 37,279 (CAB abstracts) – 
218,640 (PubMed) references. Restricting the database searches to publications from the year 
of 2010 onwards only, still by making use of the same definition as query, resulted in 
numbers of references of between 21,961 (CAB abstracts) – 88,750 (PubMed). These 
numbers illustrate the vast number of scientific reports on the topic of ‘antibiotic resistance’ 
that are present in general (Scopus, Web of Sciences), biomedical (MedLine, PubMed) and 
applied life sciences (CAB abstracts) library databases.    
 As second step, definitions for queries among the same databases were therefore 
restricted by making use of combinations in search terms, by combining the term ‘antibiotic 
resistance’ with ‘mobilome’, ‘resistome’, ‘microbiome’, ‘mobile genetic element’, 
‘pangenome’, ‘gene’, ‘self-transmissible’ and/ or ‘host range’. Further specifications on 
search definitions, based on tolerated variations in definitions and maximum number of words 
between definitions are shown in Table S1. For all combinations, queries were applied to 
these five databases, later followed by setting a restriction for reports that appeared after 2010 
only. Based on all attempted combinations, the selected numbers of non-duplicate 
publications were between 22 (antibiotic resistance AND pangenome AND mobile genetic 
element as query) and 656 (antibiotic resistance AND resistome as query) (Table S1). Some 
of the queries still delivered too high numbers for selecting out duplicate references by hand 
(antibiotic resistance AND gene), (antibiotic resistance AND microbiome), whereas for other 
queries the variation in search terms resulted in about the same number of references, which 
was the case for the combinations of ‘antibiotic resistance AND pangenome with and without 
the term mobile genetic element’ and for ‘antibiotic resistance AND gene AND self-
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transmissible AND host range, with or without the term ‘mobile genetic element’. Using the 
combinations of search terms with ‘mobilome’, ‘resistome’ and ‘pangenome’, (almost) only 
references from 2010 and later were obtained, demonstrating that most genomic and 
metagenomic-based reports related to antibiotic resistance appeared after that time (Fig. S2)   
As third step, selected references (last column in Table S1) were screened for reports 
on ‘last resort antibiotics’. This group encompassed the classes of: third, fourth and fifth 
generations of cephalosporins and carbapenems, glycopeptides, macrolides and ketolides, 
polymyxins, quinolones, aminoglycosides, ansamycins, glycylcyclines and 
aminomethylcyclines, lipopeptides and oxazolidinones. Peer-reviewed publications, based on 
associations between LRAs and MGEs and references within these publications, were further 
selected out by hand and a list of genes conferring resistances towards LRAs, eventually 
associated with MGEs, was prepared. This list was shortened on the basis of relevance to the 
aim of the study, using the advices from two leading scientists in the fields of clinical and 
veterinary bacteriology (see acknowledgements). Most relevant resistance genes of LRAs 
with eventual associations with MGEs are shown in Table S2.  
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Fig. S1. Schematic overview of the semi-systematic literature search approach conducted in 
this report.  
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Fig. S2. Number of publications that appeared after the year of 2010, obtained from five 
library databases using a semi-systematic search approach based on combinations of the term 
‘antibiotic resistance’ with ‘mobilome’ and ‘resistome’ in queried search definitions. 
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Table S1. Maximum tolerated variations in definitions and number of words is search 
definition variants based on ‘antibiotic resistance’. 
Concept Line Query 
Antibiotics resistance 1 TITLE-ABS-KEY(Antibiotic* W/3 resistan* OR anti-biotic* 
W/3 resistan* OR antimicrobial W/3 resistan* OR anti-
microbial W/3 resistan* OR multidrug W/3 resistan* OR 
MDR OR multi-drug W/3 resistan* OR "multiple drug" W/3 
resistan* OR multiple-drug W/3 resistan* OR "totally drug 
resistan*" OR "extensively drug resistan*" OR XDR OR 
"pandrug resistan*" OR "pan drug resistan*" OR PDR OR 
"plasmid mediated" W/3 resistan*) 
mobilome 2 TITLE-ABS-KEY(mobilome) 
resistome 3 TITLE-ABS-KEY(resistome) 
microbiome 4 TITLE-ABS-KEY(microbiome) 
pangenome 5 TITLE-ABS-KEY(pangenome) 
gene 6 TITLE-ABS-KEY(gene) 
self-transmissible 7 TITLE-ABS-KEY(self-transmissible OR conjugative) 
host range 8 TITLE-ABS-KEY(Host W/3 range OR hostrange) 
mobile genetic element 9 TITLE-ABS-KEY("mobile genetic element" OR "insertion 
element" OR transposon OR retrotransposon OR 
"transposable element" OR retroelement OR plasmid OR 
phage OR prophage OR bacteriophage OR resistome OR "r 
factor" OR "resistance factor") 
Antibiotics resistance 
AND mobilome 
10 1 AND 2 
Antibiotics resistance 
AND resistome 
11 1 AND 3 
Antibiotics resistance 
AND microbiome 
12 1 AND 4 
Antibiotics resistance 
AND microbiome AND 
Mobile genetic element 
13 1 AND 4 AND 9 
Antibiotics resistance 
AND pangenome 
14 1 AND 5 
Antibiotics resistance 
AND pangenome AND 
Mobile genetic element 
15 1 AND 5 AND 9 
Antibiotics resistance 
AND gene 
16 1 AND 6 
Antibiotics resistance 
AND Gene AND  
Self-transmissible 
17 1 AND 6 AND 7 
Antibiotics resistance 
AND Gene AND  
Self-transmissible AND 
Host range 
18 1 AND 6 AND 7 AND 8 
Antibiotics resistance 
AND Gene AND  
Self-transmissible AND 
Host range AND mobile 
genetic element 
19 1 AND 6 AND 7 AND 8 AND 9 
   
 63 
 
Table S2. Number of publications obtained from five library databases using a semi-systematic search approach based on variations on the term 
‘antibiotic resistance’ in queried search definitions. 
 
Queried search definition Number of references (all publications until 31-12-2018/ publications from 1-1-2010 - 31-12-2018 only) 
Scopus Web of Science CAB Abstracts MedLine PubMed Total (all 
publications) 
Antibiotic resistance 186,367/  80,579 149,951/ 87,963 37,279/ 21,961 100,160/ 50,018 218,640/ 88,750 * 
Antibiotic resistance AND Mobilome 36/ 35 41/ 40 10/ 10 22/ 22 34/ 34 51 
Antibiotic resistance AND Resistome 442/ 426 526/ 502 131/ 125 262/ 252 434/ 414 656 
Antibiotic resistance AND Microbiome 1,004/ 997 732/ 726 153/ 151 458/ 453 549/ 544 * 
Antibiotic resistance AND Microbiome AND 
Mobile genetic element 
219/ 219 165/ 165 41/ 41 130/ 130 135/ 135 296 
Antibiotic resistance AND Pangenome 29/ 29 34/ 34 3/ 3 14/ 14 26/ 26 * 
Antibiotic resistance AND Pangenome AND 
Mobile genetic element 
14/ 14 14/ 14 1/ 1 6/ 6 12/ 12 22 
Antibiotic resistance AND Gene 50,772/ 28,605 47,688/ 27,895 11,006/ 7,721 29,978/ 16,544 36.554/ 17,279 * 
Antibiotic resistance AND Gene AND  
Self-transmissible 
1,686/ 853 1,464/ 881 323/ 194  901/ 502 1.101/ 570 * 
Antibiotic resistance AND Gene AND  
Self-transmissible AND 
Host range 
118/  56 136/ 74 22/ 11 63/ 33 71/ 37 * 
Antibiotic resistance AND Gene AND  
Self-transmissible AND 
Host range AND Mobile genetic element 
116/ 54 124/ 67 20/ 10 61/ 32 67/ 35 183 
